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Metabolic alterations in children
with environmental enteric
dysfunction
Richard D. Semba1, Michelle Shardell2, Indi Trehan3,4, Ruin Moaddel2, Kenneth M. Maleta4,
M. Isabel Ordiz3, Klaus Kraemer5,6, Mohammed Khadeer2, Luigi Ferrucci2 & Mark J. Manary3,4
Environmental enteric dysfunction, an asymptomatic condition characterized by inflammation of the
small bowel mucosa, villous atrophy, malabsorption, and increased intestinal permeability, is a major
contributor to childhood stunting in low-income countries. Here we report the relationship of increased
intestinal permeability with serum metabolites in 315 children without acute malnutrition, aged 12–59
months, in rural Malawi. Increased gut permeability was associated with significant differences in
circulating metabolites that included lower serum phosphatidylcholines, sphingomyelins, tryptophan,
ornithine, and citrulline, and elevated serum glutamate, taurine, and serotonin. Our findings suggest
that environmental enteric dysfunction is characterized by alterations in important metabolites
involved in growth and differentiation and gut function and integrity.
Environmental enteric dysfunction (EED) is highly prevalent in children younger than five years of age in rural
sub-Saharan Africa, South America, and South Asia1,2. EED is strongly associated with childhood stunting1–4.
Longitudinal studies of young children in The Gambia showed that >40% of linear growth failure is attributable
to EED4. Stunting was associated with increased intestinal permeability but not with diarrhea history5. Close contact with animals, and more frequent geophagy are significant risk factors for EED in young children1,2,6. Chronic
fecal-oral transmission of pathogenic bacteria, viruses, and parasites is considered a key factor underlying EED1,2.
The pathological findings of EED include villous shortening, crypt hyperplasia, and lymphocytic infiltration7.
With the breakdown of the intestinal barrier, there is translocation of bacteria and microbial products into the
circulation, leading to chronic immune stimulation and the characteristic histopathology of EED1,2. Accordingly,
immunohistochemical studies show T-cell infiltration and elevated proinflammatory cytokines such as tumor
necrosis factor-αand interferon-γin the lamina propria7.
Increased gut permeability could potentially affect the absorption and metabolism of amino acids, proteins,
lipids, carbohydrates, and other nutrients1. However, this hypothesis has not been adequately investigated, and
the underlying biological mechanisms by which EED could affect child health and linear growth are incompletely
understood. This may explain why the many clinical trials that have been conducted with the aims of reducing gut
permeability and improving linear growth among children in low-income countries have generally failed to both
reduce gut permeability and improve child growth2. A better understanding of the basic biological mechanisms
by which EED adversely impacts child health and growth may lead to more effective interventions against EED to
reduce childhood stunting. We investigated the hypothesis that increased gut permeability is associated with concentrations of amino acids, glycerophospholipids, and sphingolipids by using a targeted metabolomics approach
to characterize serum metabolites in children with and without EED in rural Malawi. We present data on young
children from rural Malawi. Our results highlight specific metabolic alterations associated with increased gut
permeability in young children with EED that are likely to affect growth and development.

Results

Study setting. We examined the relationship between gut permeability and serum metabolites in 315 children without acute malnutrition, aged 12–59 months, from six villages in rural Malawi. The villages where the
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Characteristic1

No EED2
(n = 68)

EED2
(n = 247)

P3

Age, months

37.9 (10.5)

33.7 (12.0)

0.006

48.5

49.8

0.96

0.3 (1.0)

0.2 (0.9)

0.53

−2.4 (1.3)

−2.3 (1.3)

0.69

Stunted, %

63.2

61.1

0.75

Caretaker is mother, %

97.0

95.1

0.50

Father is alive, %

89.7

97.2

0.008

Siblings, n

3.8 (1.7)

3.7 (1.7)

0.73

Individuals that sleep in
same room as child, n

3.3 (1.7)

3.4 (1.4)

0.61

Home with a metal
roof, %

27.9

17.4

0.05

Family owns bicycle, %

58.8

61.9

0.64

Animals sleep in house, %

44.1

35.2

0.18

Water from a clean
source, %

82.3

66.0

0.009

Child uses pit latrine, %

76.5

66.0

0.18

Chamba

10.4

14.2

Female, %
Weight-for-height Z-score
Height-for-age Z-score

Village, %

Makwhira

4.5

6.1

Masika

14.9

42.9

Mayaka

38.8

22.7

Mbiza

22.4

11.7

Mitondo

9.0

2.4

<0.001

Table 1. Characteristics of the study population. 1Means (SD) or %. 2No EED (L:M <  0.15), EED
(L:M ≥  0.15). 3Students t-test for continuous variables or chi-square test for categorical variables.

children live are comprised largely of subsistence farm families who grow and consume maize as the staple crop.
Water is acquired from boreholes or nearby streams. Homes are mostly of mud and thatch. Defecation generally
occurs outdoors or in pit latrines. There is frequent contact between children and domestic animals such as
chickens and goats. Electricity, running water, and other utilities are invariably absent in the homes. The environment of these rural villages in Malawi is a typical setting for EED. The characteristics of the children with
and without EED in the study and demographic features of their household environment are shown in Table 1.
There were nearly an equal number of boys and girls. The lactulose:mannitol (L:M) ratio, assessed in the dualsugar absorption test, was used as the measure of gut permeability and intestinal absorption8. A higher L:M ratio
indicates greater gut permeability. Children with an L:M ratio ≥ 0.15 were defined as having EED.9 Serum metabolites were measured using liquid chromatography-tandem mass spectrometry10. The 139 metabolites analyzed
included 22 amino acids, 3 biogenic amines, 6 amino acid metabolites, 15 sphingolipids, 8 acylcarnitines, and 85
glycerophospholipids.

Serum metabolites differ by gut permeability.

The relationship of gut permeability with all serum
metabolites is summarized in a volcano plot in Fig. 1. There were 14 serum metabolites that were significantly
related with gut permeability. Serum tryptophan, ornithine, citrulline, four lysophosphatidylcholines (lysoPC
a C16:0, lysoPC a C18:0, lysoPC a C18:2, lysoPC a C20:4), two acyl-alkyl-phosphatidylcholines (PC ae C40:1,
PC ae C44:3), and two sphingomyelins (SM C16:0, SM C16:1) were negatively correlated with gut permeability
(L:M ratio). The general negative correlation of the different serum phosphatidylcholines and sphingomyelins
with gut permeability as displayed on the left side of the volcano plot is quite evident. Serum glutamate, serotonin, and taurine were positively correlated with gut permeability. Tryptophan that is converted to serotonin or
to kynurenine is no longer available for protein synthesis, thus, ratios of these two metabolites with tryptophan
were calculated. The adjusted Spearman correlations between gut permeability and the serotonin/tryptophan and
kynurenine/tryptophan ratio were 0.27 (P =  7.34 ×  10−7) and 0.25 (P =  6.44 ×  10−6), respectively. A summary
heatmap of the top fifty serum metabolites by gut permeability and their clusters is shown in Fig. 2. We further
investigated potential nonlinear relationships of the metabolites that were significantly correlated with gut permeability. Scatterplots and fitted regression curves (with 95% confidence intervals) using linear mixed-effects models
to address within-village clustering with natural cubic splines (3 knots) are shown for the significant metabolites
in Fig. 3 and for the serotonin/tryptophan and kynurenine/tryptophan ratios in Fig. 4. While nonlinearity is evident for some metabolites, inflection tends to occur at values of the L:M ratio where there are few data points and
therefore uncertainty in estimation.
The age-, sex-, and village-adjusted Spearman correlations between gut permeability and serum metabolites are presented for amino acids, amino acid metabolites, and biogenic amines (Supplementary Table 1),
sphingolipids and acylcarnitines (Supplementary Table 2), and glycerophospholipids (Supplementary Table 3).
The correlations between gut permeability and serum metabolites ranged between −0.214 (tryptophan) to 0.155
(serotonin). More detailed heatmaps of serum amino acids, biogenic amines, amino acid metabolites, sphingolipids,
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Figure 1. Volcano plot showing the relationship of partial Spearman correlations between the gut
permeability (L:M ratio) and serum metabolites, adjusted for age, gender, and village. Horizontal line
indicates significance at p-value of <0.027, which corresponds to a q-value <  0.05.

Figure 2. Heat map and hierarchical clustering of the 50 most significantly correlated metabolites with L:M
ratio as continuous variable, after adjustment for age, gender, and village. L:M ratio is categorized in deciles.
Z-scores shown for metabolites. Abbreviations for lipid nomenclature are described in the methods section.
Amino acid abbreviations: Trp (tryptophan), Orn (ornithine), Glu (glutamate), Cit (citrulline).
acylcarnitines, and glycerophospholipids by gut permeability are shown in Supplementary Figs 1 and 2. Exploratory
analyses showed that additional adjustment for height-for-age Z-score had little effect upon the relationship of the
estimated correlations of serum metabolites with gut permeability. The relationships between urinary mannitol
and metabolites were also explored. Only serum taurine and glutamate were associated with urinary mannitol
(r =  −0.173, P =  0.002; r =  −0.157, P = 0.006, respectively). Unadjusted median (interquartile range) of serum
metabolite concentrations in children with and without EED are shown for amino acids, biogenic amines, amino
acid metabolites, sphingolipids, acylcarnitines, and glycerophospholipids in Supplementary Tables 4–6.
Multiple machine-learning classification algorithms were used to assess the ability of the 14 metabolites
significantly correlated with L:M ratio to classify EED status (EED vs. no EED). We used the Super Learner11
algorithm to fit, internally cross-validate, and combine the results into a single classifier. Nine different classifiers were trained on a subset of the data and fit using data omitted for training via leave 10% out internal
cross-validation. Next, a weighted-average of the estimates was computed to minimize mean-square error, and
Scientific Reports | 6:28009 | DOI: 10.1038/srep28009
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Figure 3. Scatterplots and fitted regression curves using non-linear cubic splines for serum metabolites
with significant correlations with the L:M ratio. Broken lines indicate 95% confidence intervals. Data
were modeled using linear mixed effects models that include age and sex and village as a random intercept.
Correlation coefficients are shown. Abbreviations for lipid nomenclature are described in the methods section.
Amino acid abbreviations: Trp (tryptophan), Orn (ornithine), Glu (glutamate), Cit (citrulline).

the weights themselves were estimated via leave 10% out internal cross-validation (See Supplementary Appendix
for additional details). Five algorithms had positive weights (ridge regression12, generalized boosted models13,
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Figure 4. Scatterplots and fitted regression curves using non-linear cubic splines for serotonin/tryptophan
ratio and kynurenine/tryptophan ratio with L:M ratio. Broken lines indicate 95% confidence intervals. Data
were modeled using linear mixed effects models that include age and sex and village as a random intercept.
Correlation coefficients are shown.

random forests14, multivariate adaptive regression splines implemented using the earth() function in R software
version 3.2.015,16, and Bayes generalized linear models). Supplementary Figure 3 and Supplementary Appendix
Table 1 show that the metabolites have a modest ability to discriminate between children with and without EED
(cross-validated Super Learner cross-validated area under the ROC curve 0.679, 95% confidence interval 0.610,
0.747). However, the final cross-validated Super Learner model was well calibrated showing little evidence of lack
of fit (P =  0.70).

Discussion

The present study shows that children with higher gut permeability, as measured by the L:M ratio, have alterations
in serum metabolites that include lower serum phosphatidylcholines, lysophosphatidylcholines, and sphinogomyelins, lower serum tryptophan, ornithine, and citrulline, and higher serum glutamate, taurine, and serotonin.
This is the first study to apply a targeted metabolomics approach to gain insight into the pathophysiology of
EED. The results suggest that there may be abnormalities in several diverse metabolic pathways in children with
increased gut permeability, including the CDP-choline or “Kennedy pathway” for synthesis of phosphatidylcholines, the synthesis of lysophosphatidylcholines and sphingomyelins, the tryptophan-serotonin pathway, the
kynurenine pathway, and citrulline synthesis. Perturbations in these pathways and imbalance of metabolites could
have potential adverse consequences for child health and growth. The individual pathways are discussed below.
Phosphatidylcholines, the dominant phospholipids in cell membranes and in the circulation, play a major
role in cell proliferation, differentiation, and growth17. Phosphatidylcholines are essential for assembly and secretion of very low-density lipoproteins and high-density lipoproteins by the liver18. Phosphatidylcholines are the
main active component of pulmonary surfactant and are vital to pulmonary function19. Phosphatidylcholines
and lysophosphatidylcholines comprise >90% of the lipids in the protective mucus layer of the gastrointestinal
tract20. Phosphatidylcholines are synthesized via the CDP-choline pathway in three enzymatic steps from dietary
choline17. Phosphatidylcholines can also be synthesized via the phosphatidylethanolamine N-methyltransferase
(PEMT) pathway. However, since the PEMT pathway accounts for ~30% of hepatic synthesis of phosphatidylcholines, it is only quantitatively important in the liver and cannot meet the body’s needs. Thus, choline is considered
an essential nutrient21. The availability of phosphatidylcholine affects lysophosphatidylcholine, which is produced
from the hydrolysis of phosphatidylcholine. Lysophosphatidylcholines are important constituents of biological
membranes and bioactive phospholipids involved in inflammation22.
Since sphingomyelins are the dominant sphingolipids in membranes of mammalian cells, especially the outer
leaflet, the endocytic recycling compartment, and the trans Golgi network, they may affect a large number of
biological mechanisms. For example, sphingomyelins serve as a precursor to bioactive sphingolipids, are building
blocks of lipid rafts, regulate plasma membrane homeostasis, and are involved in T cell activation and differentiation23–25. Sphingomyelins play a key role in the myelination of the central nervous system during the development
of infants and young children26.
Tryptophan is an essential amino acid for protein synthesis as well as a precursor to the neurotransmitter serotonin. The major route for tryptophan metabolism is the kynurenine pathway in which tryptophan is oxidized
by cleavage of the indole ring27. Tryptophan that is metabolized to serotonin or the kynurenine pathway is lost to
protein synthesis27. Plasma tryptophan is decreased during inflammation or infection due to increased tryptophan oxidation27. The present study shows that the serotonin/tryptophan and kynurenine/tryptophan ratios are
significantly correlated with gut permeability. Limitation of tryptophan availability for protein synthesis could
Scientific Reports | 6:28009 | DOI: 10.1038/srep28009
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potentially have adverse consequences for child growth. Dietary tryptophan limitation in Sprague Dawley rats
resulted in severe growth restriction of young animals28. About 5% of dietary tryptophan is degraded to indole
and other derivatives by bacteria in the gut lumen29. Possible mechanisms by which EED could affect tryptophan
metabolism is through increased tryptophan degradation by altered gut microbiota, or through alterations in
tryptophan transport by amino acid transporters29 in damaged enterocytes.
In contrast to the other amino acids that circulate in free form, about 80–90% of tryptophan is bound to
albumin in the circulation, while the remaining free form can be transported across the blood-brain barrier27.
Serotonin does not cross the blood-brain barrier, thus, tryptophan can give rise to two separate pools of serotonin
in the brain and in the periphery, where it is mostly found in the gastrointestinal mucosa29. A limitation of the
present study is that serum albumin was not measured. About 95% of total serotonin content in the human body
is present in the gut, primarily in enterochromaffin cells of the intestinal mucosa30. Enterochromaffin cells act as
local sensory transducers that respond to various chemical and mechanical stimuli in the gut31. Serotonin is synthesized from tryptophan through hydroxylation by tryptophan hydroxylase (TPH) followed by decarboxylation
by aromatic acid decarboxylase (AADC). Serotonin mediates gastrointestinal functions that include peristalsis,
secretion, vasodilation, and perception of pain or nausea31. Serotonin and one if its receptors, 5-HT3, are implicated as modulators of gastrointestinal inflammation in inflammatory bowel disease31, and the association with
increased gut permeability suggests it may play a role in EED. Serotonin is removed from the intestinal mucosa by
the serotonin-selective reuptake transporter (SERT). The underlying cause of elevated serum serotonin in children with EED is unclear. Possible biological mechanisms include upregulation of enzymes involved in serotonin
synthesis, TPH and AADC, or a decrease in SERT expression during EED.
Serum glutamate concentrations were elevated in children with increased gut permeability. Glutamate, a
non-essential amino acid, plays many important roles, such as providing a link between the tricarboxylic acid
cycle and urea cycle in energy generation, serving in hepatic amino acid catabolism, being a precursor to glutathione, and acting as the primary fast excitatory neurotransmitter32,33. Glutamate, a main constituent of dietary
protein, is a major oxidative fuel for the small intestine and is almost completely metabolized by the gut on first
pass, presumably in the entrocytes32. Glutamate is also used for protein synthesis in the intestinal mucosa and
can be used by enterocytes to produce aspartate, alanine, proline, ornithine, and citrulline34. Whether elevated
serum glutamate arises from decreased utilization of glutamate by the gut, increased catabolism of amino acids
such as arginine, ornithine, proline, histidine and glutamine, or other mechanisms in children with increased gut
permeability is not known.
Taurine is an abundant free amino acid that plays diverse biological roles in membrane stabilization, cell volume regulation, mitochondrial function, growth and development, lung function, the conjugation of bile acids,
and as an antioxidant35,36. Taurine is synthesized via the cysteine sulfinic acid pathway. The biological mechanisms
that contribute to elevated serum taurine concentrations in children with EED are unclear.
Serum citrulline is considered to reflect total small bowel enterocyte mass since circulating citrulline is mainly
produced by enterocytes37,38. Low circulating citrulline occurs in patients with short bowel syndrome, villous
atrophy states, and Crohn’s disease38. Thus, serum citrulline has been proposed as a potential marker for EED2.
Citrulline is synthesized in enterocytes via the conversion of glutamine or arginine to ornithine39. Citrulline is
then produced from the conversion of ornithine by ornithine transcarbamylase38. The association of both low
serum citrulline and ornithine with increased gut permeability may reflect reduced small bowel enterocyte mass.
The present study suggests several serum metabolites as candidate biomarkers for EED: citrulline, ornithine,
glutamate, taurine, serotonin, tryptophan, serotonin/tryptophan ratio, kynurenine/tryptophan ratio, and phosphatidylcholines and sphingomyelins. However, the correlations between specific serum metabolites and gut permeability were modest, which may limit their use as biomarkers. Other blood biomarkers have been proposed as
marker for gut permeability, including zonulin, anti-endotoxin core antibody, and soluble CD142. Further studies
are needed to determine the utility of selected serum metabolites as biomarkers of EED, including consideration
of the specificity of the markers.
The present study is limited in that the findings cannot necessarily be generalized to all settings where children
are at risk for EED. There may be differences in diet and environment that could potentially modify the relationship between increased gut permeability and circulating metabolites. Urinary lactulose and mannitol in the
present study were measured using high performance liquid chromatography (HPLC). A recent analysis suggests
that LC-MS/MS platforms using multiple reaction monitoring for measurement of urinary lactulose and mannitol is more accurate, although measurements using either HPLC or LC-MS/MS are highly correlated40. Another
limitation is that other markers for EED were not measured in this study.
In conclusion, increased gut permeability is associated with alterations in important metabolites involving
growth and differentiation and gut function and integrity. Further studies are needed to elucidate the relationship
between metabolic alterations in EED and specific biological mechanisms, including insufficient dietary choline
and tryptophan, the effects of increased gut permeability on metabolic pathways involving glutamine, serotonin,
and taurine, and to corroborate the relationship of gut permeability with serum citrulline, ornithine, and serotonin/tryptophan and kynurenine/tryptophan ratios.

Methods

Study design and participants. We examined the relationship of EED with serum metabolites in a
cross-sectional study of 315 children, aged 12–59 months, seen in six villages (Masika, Makhwira, Mitondo,
Mibiza, Chamba, and Mayaka) in rural southern Malawi in 2011. Children were eligible for the study if they had
no evidence of kwashiorkor, congenital or chronic disease, caretaker-reported diarrhea, or were under treatment
for malnutrition. Children had anthropometry conducted by experienced field workers. Weight was measured
to the nearest 5 g using a digital scale (Seca 344, Chino, CA). Height was measured to the nearest 0.1 cm using a
rigid height board (Seca 417). The dual sugar permeability test was used as the standard non-invasive measure
Scientific Reports | 6:28009 | DOI: 10.1038/srep28009
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of gut integrity, as described in detail elsewhere3. The urinary L:M ratio was used as the measure of intestinal
mucosal permeability8. Lactulose and mannitol were measured using high-performance liquid chromatography3.
Chichewa-speaking Malawian research nurses obtained written and oral informed consent from each child’s caretaker before enrollment in the study. Community consent for the study also was obtained from the village chief
and local health officials. The protocol for this study was approved by the College of Medicine Research Ethics
Committee of the University of Malawi, the Human Research Protection Office of Washington University in St.
Louis, and the Johns Hopkins School of Medicine Institutional Review Board. The methods were carried out in
accordance with the approved guidelines.

Measurement of serum metabolites. Venous blood was drawn by study nurses and doctors. Serum
samples were processed, aliquoted, and snap frozen in liquid nitrogen in cryovials within 4 h of blood drawing.
Cryovials were transferred to storage at −80 °C. Serum metabolites were measured using liquid chromatography
tandem mass spectrometry (LC-MS/MS). Metabolites were extracted and concentrations are measured using the
AbsoluteIDQ p180 kit (Biocrates Life Sciences AG, Innsbruck, Austria) following the manufacturers protocol for
a 5500 QTrap (Sciex, Framingham, MA) mass spectrometer equipped with an electrospray ionization source, a
Shimadzu CBM-20A command module, LC-20AB pump, and a Shimadzu SIL-20AC-HT autosampler, a CTO10Ac column oven heater, and running with Analyst 1.5.2 software, as described in detail elsewhere10. Briefly,
10 μL of serum was pipetted onto a 96 well Biocrates kit. The samples were dried at room temperature (RT) for
30 min. 50 μL of 5% PITC reagent was added and incubated for 20 min and the plate was dried under nitrogen
for 1 h. 300 μL of 5 mM ammonium acetate in methanol was added and incubated at RT on a shaker (450 rpm)
for 30 min. The plate was centrifuged at 500 × g for 2 min and labeled; 50 μL of each sample was transferred to
a 96 deep well LC plate, and 10 uL of each sample was transferred to the 96 deep well FIA plate. To the LC plate,
450 μl of 40% methanol (in HPLC grade water) was added. To the FIA plate, 490 μL of FIA running solvent was
added. 10 μL was injected onto the Eclipse XDB C18, 3.5 μm, 3.0 × 100 mm with a Phenomenex C18 Security
Guard Cartridge, 3.0 mm ID. The mobile phase consisted of solvent A (water containing 0.2% formic acid) and
solvent B (acetonitrile containing 0.2% formic acid), with the following gradient: 0–0.5 min 0% B, 5.5 min: 95%
B; 6.5 min: 95% B; 7.0 min: 0% B; 9.5 min: 0% B. LC plate evaluation of the samples was carried out using the
MetIDQ software. The FIA plate was run with 20 μL injection directly onto the MS at a flow of 30 μL/min with
water/acetonitrile (1:1) containing 0.2% formic acid as the mobile phase, with the following flow rate program:
0–1.6 min: 30 μL/min; 2.4 min: 200 μL/min; 2.80 min: 200 μL/min and 3.00 min: 30 μL/min. Concentrations were
calculated using the Analyst/MetIDQ software and reported in μmol/L. The method measured 140 metabolites,
including 22 amino acids, 3 biogenic amines, 6 amino acid metabolites, 15 sphingolipids, 8 acylcarnitines, and
85 glycerophospholipids (lyso-, diacyl-, and acyl-alkyl phosphatidylcholines). Glycerophospholipids are differentiated on the basis of ester and ether bonds in the glycerol moiety. Diacyl or “aa” indicates that fatty acids are
bound with ester bonds at the sn-1 and sn-2 positions on the glycerol backbone. Acyl-alkyl or “ae” indicates that
the fatty acid at the sn-1 position is bound with an ether bond. The total number of carbon atoms and double
bonds in fatty acid chains is represented by “C x:y”, where x denotes the number of carbons and y denotes the
number of double bonds. Phosphatidylcholine (PC), lysophosphatidylcholine (lysoPC), and sphingomyelin (SM),
and hydroxysphingomyelin (SM [OH]) are used as abbreviations. Standard amino acid abbreviations are used
in all figures. Acylcarnitines were designated with abbreviations: carnitine (C0), acetylcarnitine (C2), proprionylcarnitine (C3), butyrylcarnitine (C4), hydroxybutyrylcarnitine (C4-OH [C3-DC]), hexadecanoylcarnitine
(C16), octadecenoylcarnitine (C18), and octadecadienylcarnitine (C18:1). Dimethylarginines were designated
with abbreviations: total dimethylarginine (TDMA), symmetric dimethylarginine (SDMA), and asymmetric
dimethylarginine (ADMA). The MS spectra were evaluated using Analyst/MetIDQ (Biocrates) software. Human
serum samples spiked with standard metabolites were used to monitor the reproducibility of the assay. Serum
metabolites that were below the limit of quantification were excluded from the data analyses. The inter-assay and
intra-assay coefficients of variation ranged from 5% to 15% for nearly all analytes.
Statistical analysis. Exploratory data analyses using histograms and boxplots were used to examine the
distribution of the L:M ratio and serum metabolites. The L:M ratio is a measure of gut permeability. Spearman
correlations of each metabolite with L:M ratio were estimated with and without adjustment for age, gender, and
village. A false discovery rate approach was used to correct for multiple testing; the bootstrap method was used
to compute q-values41–43. This analysis was carried out using the pcor.test() function in the ppcor package in R
software version 3.2.0. Classification modeling using nine machine-learning algorithms was used to examine the
ability of the 14 metabolites that were significantly correlated with L:M ratio to classify EED status (L:M ≥  0.15
versus L:M <  0.15). SuperLearner11, an ensembling approach to machine learning, implemented multiple individual machine-learning algorithms (e.g., logistic regression). The cross-validated results from the individual
machine-learning algorithms were combined via weighted average to minimize a cross-validated mean squared
error (and potentially fit the data better than each individual algorithm). Details of SuperLearner, including computation of estimates, cross-validation, and metrics to assess discrimination and calibration, are described in
detail in the Supplementary Appendix. Classification modeling was carried out using the SuperLearner() and
CV.SuperLearner() functions in the SuperLearner package in R software version 3.2.044.
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